Lundbeck is a global pharmaceutical company specializing in brain diseases, while Iambic Therapeutics is a biotech firm using AI-driven platforms for drug discovery. Their strategic partnership focuses on developing an AI-discovered small molecule therapy for migraines, aiming to accelerate drug development and improve success rates.